MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

Journal of Experimental Medicine

Volumn 210, Issue 13, 2013, Pages 2921-2937

  Molnarfi, Nicolas ^a,i,j   Schulze Topphoff, Ulf ^a   Weber, Martin S ^a,k   Patarroyo, Juan C ^a   Prod'homme, Thomas ^a   Varrin Doyer, Michel ^a   Shetty, Aparna ^a   Linington, Christopher ^b   Slavin, Anthony J ^c   Hidalgo, Juan ^d   Jenne, Dieter E ^e   Wekerle, Hartmut ^e   Sobel, Raymond A ^f   Bernard, Claude C A ^g   Shlomchik, Mark J ^h   Zamvil, Scott S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MONASH UNIVERSITY   (Australia)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^j UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^k UNIVERSITY OF GÖTTINGEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; B LYMPHOCYTE RECEPTOR; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; IMMUNOGLOBULINS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN SHEATH; TH1 CELLS; TH17 CELLS;

EID: 84890819172     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130699     Document Type: Article

References (63)

1. Amor, S., N. Groome, C. Linington, M.M. Morris, K. Dornmair, M.V. Gardinier, J.M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:4349-4356.
2. Bar-Or, A., P.A. Calabresi, D. Arnold, C. Markowitz, S. Shafer, L.H. Kasper, E. Waubant, S. Gazda, R.J. Fox, M. Panzara, et al. 2008. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann. Neurol. 63:395-400. [published erratum appears in Ann. Neurol. 2008. 63:803] http://dx.doi.org/10.1002/ana.21363
3. Bar-Or, A., L. Fawaz, B. Fan, P.J. Darlington, A. Rieger, C. Ghorayeb, P.A. Calabresi, E. Waubant, S.L. Hauser, J. Zhang, and C.H. Smith. 2010. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann. Neurol. 67:452-461. http://dx.doi.org/10.1002/ana.21939
4. Barr, T.A., P. Shen, S. Brown, V. Lampropoulou, T. Roch, S. Lawrie, B. Fan, R.A. O'Connor, S.M. Anderton, A. Bar-Or, et al. 2012. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209:1001-1010. http://dx.doi.org/10.1084/jem.20111675
5. Basso, A.S., D. Frenkel, F.J. Quintana, F.A. Costa-Pinto, S. Petrovic-Stojkovic, L. Puckett, A. Monsonego, A. Bar-Shir, Y. Engel, M. Gozin, et al. 2008. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J. Clin. Invest.. 118:1532-1543. http://dx.doi.org/10.1172/JCI33464
6. Bettelli, E., M. Pagany, H.L. Weiner, C. Linington, R.A. Sobel, and V.K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197:1073-1081. http://dx.doi.org/10.1084/jem.20021603
7. Bettelli, E., D. Baeten, A. Jäger, R.A. Sobel, and V.K. Kuchroo. 2006a. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 116:2393-2402. http://dx.doi.org/10.1172/JCI28334
8. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T.B. Strom, M. Oukka, H.L. Weiner, and V.K. Kuchroo. 2006b. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 441:235-238. http://dx.doi.org/10.1038/nature04753
9. Blennow, K., P. Fredman, A. Wallin, C.G. Gottfries, H. Frey, T. Pirttilä, I. Skoog, C. Wikkelsö, and L. Svennerholm. 1994. Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis. J. Neurol. Sci. 121:90-96. http://dx.doi.org/10.1016/0022-510X(94)90161-9
10. Breithaupt, C., B. Schäfer, H. Pellkofer, R. Huber, C. Linington, and U. Jacob. 2008. Demyelinating myelin oligodendrocyte glycoproteinspecific autoantibody response is focused on one dominant conformational epitope region in rodents. J. Immunol. 181:1255-1263.
11. Brück, W., R. Gold, B.T. Lund, C. Oreja-Guevara, A. Prat, C.M. Spencer, L. Steinman, M. Tintoré, T.L. Vollmer, M.S. Weber, et al. 2013. Therapeutic decisions in multiple sclerosis: Moving beyond efficacy. JAMA Neurol. 70:1315-1324. http://dx.doi.org/10.1001/jamaneurol.2013.3510
12. Chan, O.T., L.G. Hannum, A.M. Haberman, M.P. Madaio, and M.J. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189:1639-1648. http://dx.doi.org/10.1084/jem.189.10.1639
13. Chen, J., M. Trounstine, F.W. Alt, F. Young, C. Kurahara, J.F. Loring, and D. Huszar. 1993. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int. Immunol. 5:647-656. http://dx.doi.org/10.1093/intimm/5.6.647
14. Clements, C.S., H.H. Reid, T. Beddoe, F.E. Tynan, M.A. Perugini, T.G. Johns, C.C. Bernard, and J. Rossjohn. 2003. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc. Natl. Acad. Sci. USA. 100:11059-11064. http://dx.doi.org/10.1073/pnas.1833158100
15. Constant, S., D. Sant'Angelo, T. Pasqualini, T. Taylor, D. Levin, R. Flavell, and K. Bottomly. 1995a. Peptide and protein antigens require distinct antigenpresenting cell subsets for the priming of CD4+ T cells. J. Immunol. 154:4915-4923.
16. Constant, S., N. Schweitzer, J. West, P. Ranney, and K. Bottomly. 1995b. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J. Immunol. 155:3734-3741.
17. Cross, A.H., J.L. Stark, J. Lauber, M.J. Ramsbottom, and J.A. Lyons. 2006. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 180:63-70. http://dx.doi.org/10.1016/j.jneuroim.2006.06.029
18. Crotty, S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29:621-663. http://dx.doi.org/10.1146/annurev-immunol-031210-101400
19. Deenick, E.K., A. Chan, C.S. Ma, D. Gatto, P.L. Schwartzberg, R. Brink, and S.G. Tangye. 2010. Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling. Immunity. 33:241-253. http://dx.doi.org/10.1016/j.immuni.2010.07.015
20. Fillatreau, S., C.H. Sweenie, M.J. McGeachy, D. Gray, and S.M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944-950. http://dx.doi.org/10.1038/ni833
21. Fox, R.J., A. Thompson, D. Baker, P. Baneke, D. Brown, P. Browne, D. Chandraratna, O. Ciccarelli, T. Coetzee, G. Comi, et al. 2012. Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS. Mult. Scler. 18:1534-1540. http://dx.doi.org/10.1177/1352458512458169
22. Genain, C.P., M.H. Nguyen, N.L. Letvin, R. Pearl, R.L. Davis, M. Adelman, M.B. Lees, C. Linington, and S.L. Hauser. 1995. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96:2966-2974. http://dx.doi.org/10.1172/JCI118368
23. Gu, H., Y.R. Zou, and K. Rajewsky. 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell. 73:1155-1164. http://dx.doi.org/10.1016/0092-8674(93)90644-6
24. Harvey, B.P., R.J. Gee, A.M. Haberman, M.J. Shlomchik, and M.J. Mamula. 2007. Antigen presentation and transfer between B cells and macrophages. Eur. J. Immunol. 37:1739-1751. http://dx.doi.org/10.1002/eji.200636452
25. Hauser, S.L., E. Waubant, D.L. Arnold, T. Vollmer, J. Antel, R.J. Fox, A. Bar-Or, M. Panzara, N. Sarkar, S. Agarwal, et al; HERMES Trial Group. 2008. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358:676-688. http://dx.doi.org/10.1056/NEJMoa0706383
26. Hjelmström, P., A.E. Juedes, J. Fjell, and N.H. Ruddle. 1998. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161:4480-4483.
27. Isaksson, M., B.A. Lundgren, K.M. Ahlgren, O. Kämpe, and A. Lobell. 2012. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE. Eur. J. Immunol. 42:2555-2563. http://dx.doi.org/10.1002/eji.201142239
28. Kappos, L., D. Li, P.A. Calabresi, P. O'Connor, A. Bar-Or, F. Barkhof, M. Yin, D. Leppert, R. Glanzman, J. Tinbergen, et al. 2011. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebocontrolled, multicentre trial. Lancet. 378:1779-1787. http://dx.doi.org/10.1016/S0140-6736(11)61649-8
29. Krishnamoorthy, G., H. Lassmann, H. Wekerle, and A. Holz. 2006. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 116:2385-2392. http://dx.doi.org/10.1172/JCI28330
30. Kuchroo, V.K., A.C. Anderson, H. Waldner, M. Munder, E. Bettelli, and L.B. Nicholson. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20:101-123. http://dx.doi.org/10.1146/annurev.immunol.20.081701.141316
31. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature. 314:537-539. http://dx.doi.org/10.1038/314537a0
32. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:443-454.
33. Linnington, C., M. Webb, and P.L. Woodhams. 1984. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6:387-396. http://dx.doi.org/10.1016/0165-5728(84)90064-X
34. Litzenburger, T., R. Fässler, J. Bauer, H. Lassmann, C. Linington, H. Wekerle, and A. Iglesias. 1998. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med. 188:169-180. http://dx.doi.org/10.1084/jem.188.1.169
35. Lyons, J.A., M. San, M.P. Happ, and A.H. Cross. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29:3432-3439. http://dx.doi.org/10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2
36. Lyons, J.A., M.J. Ramsbottom, and A.H. Cross. 2002. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32:1905-1913. http://dx.doi.org/10.1002/1521-4141 (200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L
37. Magliozzi, R., O. Howell, A. Vora, B. Serafini, R. Nicholas, M. Puopolo, R. Reynolds, and F. Aloisi. 2007. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 130:1089-1104. http://dx.doi.org/10.1093/brain/awm038
38. Marriott, J.J., and P.W. O'Connor. 2010. Emerging therapies in relapsingremitting multiple sclerosis. Rev. Recent Clin. Trials. 5:179-188. http://dx.doi.org/10.2174/157488710792007275
39. Marta, C.B., A.R. Oliver, R.A. Sweet, S.E. Pfeiffer, and N.H. Ruddle. 2005. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc. Natl. Acad. Sci. USA. 102:13992-13997. http://dx.doi.org/10.1073/pnas.0504979102
40. Martin, Mdel.P., P.D. Cravens, R. Winger, B.C. Kieseier, S. Cepok, T.N. Eagar, S.S. Zamvil, M.S. Weber, E.M. Frohman, B.K. Kleinschmidt-Demasters, et al. 2009. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab. Arch. Neurol. 66:1016-1020. http://dx.doi.org/10.1001/archneurol.2009.157
41. Matsushita, T., K. Yanaba, J.D. Bouaziz, M. Fujimoto, and T.F. Tedder. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118:3420-3430.
42. McDevitt, H.O., B.D. Deak, D.C. Shreffler, J. Klein, J.H. Stimpfling, and G.D. Snell. 1972. Genetic control of the immune response. Mapping of the Ir-1 locus. J. Exp. Med. 135:1259-1278. http://dx.doi.org/10.1084/jem.135.6.1259
43. Meinl, E., M. Krumbholz, and R. Hohlfeld. 2006. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann. Neurol. 59:880-892. http://dx.doi.org/10.1002/ana.20890
44. Menge, T., H.C. von Büdingen, P.H. Lalive, and C.P. Genain. 2007. Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA. Eur. J. Immunol. 37:3229-3239. http://dx.doi.org/10.1002/eji.200737249
45. O'Neill, S.K., M.J. Shlomchik, T.T. Glant, Y. Cao, P.D. Doodes, and A. Finnegan. 2005. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J. Immunol. 174:3781-3788.
46. Okuda, Y., S. Sakoda, H. Fujimura, Y. Saeki, T. Kishimoto, and T. Yanagihara. 1999. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. J. Neuroimmunol. 101:188-196. http://dx.doi.org/10.1016/S0165-5728(99)00139-3
47. Oliver, A.R., G.M. Lyon, and N.H. Ruddle. 2003. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 171:462-468.
48. Phan, T.G., I. Grigorova, T. Okada, and J.G. Cyster. 2007. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat. Immunol. 8:992-1000. http://dx.doi.org/10.1038/ni1494
49. Pöllinger, B., G. Krishnamoorthy, K. Berer, H. Lassmann, M.R. Bösl, R. Dunn, H.S. Domingues, A. Holz, F.C. Kurschus, and H. Wekerle. 2009. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 206:1303-1316. http://dx.doi.org/10.1084/jem.20090299
50. Quintana, A., M. Erta, B. Ferrer, G. Comes, M. Giralt, and J. Hidalgo. 2013. Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior. Brain Behav. Immun. 27:162-173. http://dx.doi.org/10.1016/j.bbi.2012.10.011
51. Roelants, G. 1972. Antigen recognition by B and T lymphocytes. Curr. Top. Microbiol. Immunol. 59:135-165.
52. Sawcer, S., G. Hellenthal, M. Pirinen, C.C. Spencer, N.A. Patsopoulos, L. Moutsianas, A. Dilthey, Z. Su, C. Freeman, S.E. Hunt, et al; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 476:214-219. http://dx.doi.org/10.1038/nature10251
53. Schluesener, H.J., R.A. Sobel, C. Linington, and H.L. Weiner. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139:4016-4021.
54. Schwartz, R.H. 1985. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu. Rev. Immunol. 3:237-261. http://dx.doi.org/10.1146/annurev.iy.03.040185.001321
55. Shimoda, M., T. Li, J.P.S. Pihkala, and P.A. Koni. 2006. Role of MHC class II on memory B cells in post-germinal center B cell homeostasis and memory response. J. Immunol. 176:2122-2133.
56. Slavin, A.J., J.M. Soos, O. Stuve, J.C. Patarroyo, H.L. Weiner, A. Fontana, E.K. Bikoff, and S.S. Zamvil. 2001. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J. Clin. Invest. 108:1133-1139.
57. van der Veen, R.C., J.L. Trotter, and J.A. Kapp. 1992. Immune processing of proteolipid protein by subsets of antigen-presenting spleen cells. J. Neuroimmunol. 38:139-146. http://dx.doi.org/10.1016/0165-5728(92)90098-6
58. Vinuesa, C.G., S.G. Tangye, B. Moser, and C.R. Mackay. 2005. Follicular B helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 5:853-865. http://dx.doi.org/10.1038/nri1714
59. von Büdingen, H.C., A. Bar-Or, and S.S. Zamvil. 2011. B cells in multiple sclerosis: connecting the dots. Curr. Opin. Immunol. 23:713-720. http://dx.doi.org/10.1016/j.coi.2011.09.003
60. Weber, M.S., T. Prod'homme, J.C. Patarroyo, N. Molnarfi, T. Karnezis, K. Lehmann-Horn, D.M. Danilenko, J. Eastham-Anderson, A.J. Slavin, C. Linington, et al. 2010. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann. Neurol. 68:369-383. http://dx.doi.org/10.1002/ana.22081
61. Wong, F.S., L. Wen, M. Tang, M. Ramanathan, I. Visintin, J. Daugherty, L.G. Hannum, C.A. Janeway Jr., and M.J. Shlomchik. 2004. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes. 53:2581-2587. http://dx.doi.org/10.2337/diabetes.53.10.2581
62. Zamvil, S.S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579-621. http://dx.doi.org/10.1146/annurev.iy.08.040190.003051
63. Zeine, R., and T. Owens. 1992. Direct demonstration of the infiltration of murine central nervous system by Pgp-1/CD44high CD45RB(low) CD4+ T cells that induce experimental allergic encephalomyelitis. J. Neuroimmunol. 40:57-69. http://dx.doi.org/10.1016/0165-5728(92)90213-5